NO951061D0 - Antibody conjugates with improved properties - Google Patents

Antibody conjugates with improved properties

Info

Publication number
NO951061D0
NO951061D0 NO951061A NO951061A NO951061D0 NO 951061 D0 NO951061 D0 NO 951061D0 NO 951061 A NO951061 A NO 951061A NO 951061 A NO951061 A NO 951061A NO 951061 D0 NO951061 D0 NO 951061D0
Authority
NO
Norway
Prior art keywords
improved properties
antibody conjugates
conjugates
antibody
properties
Prior art date
Application number
NO951061A
Other languages
Norwegian (no)
Other versions
NO951061L (en
Inventor
Brendan Murray
Terence O'reilly
Gerd Pluschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO951061D0 publication Critical patent/NO951061D0/en
Publication of NO951061L publication Critical patent/NO951061L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO951061A 1994-03-21 1995-03-20 Antibody conjugates with improved properties NO951061L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94810173 1994-03-21

Publications (2)

Publication Number Publication Date
NO951061D0 true NO951061D0 (en) 1995-03-20
NO951061L NO951061L (en) 1995-09-22

Family

ID=8218230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951061A NO951061L (en) 1994-03-21 1995-03-20 Antibody conjugates with improved properties

Country Status (11)

Country Link
JP (1) JPH0820545A (en)
KR (1) KR950031111A (en)
AU (1) AU1481795A (en)
CA (1) CA2144936A1 (en)
FI (1) FI951276A (en)
HU (1) HUT71776A (en)
IL (1) IL113022A (en)
NO (1) NO951061L (en)
NZ (1) NZ270734A (en)
RU (1) RU95104325A (en)
ZA (1) ZA952269B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865737B1 (en) * 2004-02-03 2006-03-31 Anteis Sa BIOCOMPATIBLE RETICLE GEL

Also Published As

Publication number Publication date
JPH0820545A (en) 1996-01-23
ZA952269B (en) 1995-09-21
AU1481795A (en) 1995-09-28
NZ270734A (en) 1997-05-26
IL113022A0 (en) 1995-06-29
NO951061L (en) 1995-09-22
RU95104325A (en) 1996-12-27
HU9500586D0 (en) 1995-04-28
CA2144936A1 (en) 1995-09-22
FI951276A0 (en) 1995-03-17
KR950031111A (en) 1995-12-18
IL113022A (en) 2000-02-29
HUT71776A (en) 1996-01-29
FI951276A (en) 1995-09-22

Similar Documents

Publication Publication Date Title
DE69935516D1 (en) ANTIBODIES WITH IMPROVED PRODUCTABILITY
ATE394489T1 (en) STREPTOCOCCUS ANTIGENS
DE69720320D1 (en) Interferon conjugates
NO955167D0 (en) Monoclonal anti-
DK80696A (en) Binding with trash mechanism
ID16966A (en) PRESSURE ANTIBODY PROPERTIES
DK145493D0 (en) ANTIBODY
DK1421956T3 (en) Polyol-IFN- beta conjugates
DE59501319D1 (en) Benzylidene Norcampher Derivatives
DE69524185D1 (en) TWO ROLLS-casting
DE69529288D1 (en) WATER-SOLUBLE POLYEN CONJUGATES
NO972868D0 (en) Oligonucleotide-dendrimer conjugates
DE59507277D1 (en) Folder
NO974924L (en) Modified polypeptides with increased immunogenicity
ID28905A (en) ANTIBODIES WITH HIGH AFINITY
NO951061D0 (en) Antibody conjugates with improved properties
KR950029468U (en) Smuggling
SE9002479D0 (en) ANTIBODY CONJUGATES
DE69123256T2 (en) ANTIQUE-ANTIBODY CONJUGATES
DE9404605U1 (en) folder
DE29521724U1 (en) folder
SE8902432D0 (en) ANTIBODY CONJUGATES
FI940841A0 (en) Lockoeppnare Foer can with undertryck
DE9405936U1 (en) Transition piece
DE9411245U1 (en) Sliding gate